Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Lung Neoplasms and DNMT3A[original query] |
|---|
| Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2012 Jul . Kim MS, Kim YR, Yoo NJ, Lee SH |
| Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
| miRSNPs of miR1274 and miR3202 Genes that Target MeCP2 and DNMT3b Are Associated with Lung Cancer Risk: A Study Conducted on MassARRAY Genotyping. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2016 35 (3): 223-236. Ozbayer Cansu, Degirmenci Irfan, Ustuner Derya, Ak Guntulu, Saydam Faruk, Colak Ertugrul, Gunes Hasan Veysi, Metintas Muzaff |
| The rs1550117 A>G variant in DNMT3A gene promoter significantly increases non-small cell lung cancer susceptibility in a Han Chinese population. Oncotarget 2017 Apr 8 (14): 23470-23478. Wang Jingdong, Li Chade, Wan Fengting, Li Zhou, Zhang Jingli, Zhang Jiankun, Feng Xianhong, Tang Liang, Chen Bife |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non-small-cell lung cancer. Bioengineered 2021 2 12 (1): 791-802. Zheng Songbai, Wang Xiaodan, Fu Ying, Li Beibei, Xu Jianhua, Wang Haifang, Huang Zhen, Xu Hui, Qiu Yurong, Shi Yaozhou, Li K |
Common and rare variant associations with clonal haematopoiesis phenotypes.
Nature 2022 11 612 (7939): 301-309. Kessler Michael D, Damask Amy, O'Keeffe Sean, Banerjee Nilanjana, Li Dadong, Watanabe Kyoko, Marketta Anthony, Van Meter Michael, Semrau Stefan, Horowitz Julie, Tang Jing, Kosmicki Jack A, Rajagopal Veera M, Zou Yuxin, Houvras Yariv, Ghosh Arkopravo, Gillies Christopher, Mbatchou Joelle, White Ryan R, Verweij Niek, Bovijn Jonas, Parikshak Neelroop N, LeBlanc Michelle G, Jones Marcus, , , Glass David J, Lotta Luca A, Cantor Michael N, Atwal Gurinder S, Locke Adam E, Ferreira Manuel A R, Deering Raquel, Paulding Charles, Shuldiner Alan R, Thurston Gavin, Ferrando Adolfo A, Salerno Will, Reid Jeffrey G, Overton John D, Marchini Jonathan, Kang Hyun M, Baras Aris, Abecasis Gonçalo R, Jorgenson Er |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Blood advances 2024 6 . Kevin T Nead, Taebeom Kim, LiJin Joo, Tina McDowell, Justin Wong, Irenaeus Chi-Chung Chan, Elizabeth Brock, Jing Zhao, Ting Xu, Chad Tang, Chang-Lung Lee, Jun-Ichi Abe, Kelly L Bolton, Zhongxing Liao, Paul Scheet, Steven H L |
- Page last reviewed:Feb 1, 2024
- Content source: